Greenwich LifeSciences receives noncompliance notification from Nasdaq

Greenwich LifeSciences announced that on April 16, the company received notification from Nasdaq notifying the company that, because it has not yet filed its annual report on Form 10-K for the fiscal year ended December 31, 2025, the company is not currently in compliance with Nasdaq Listing Rule 5250, which requires timely filing of periodic financial reports with the Securities and Exchange Commission. The notice has no immediate effect on the listing or trading of the company’s common stock, which continues to trade on the Nasdaq Capital Market under the symbol (GLSI). The company plans to file its Form 10-K for the fiscal year ended December 31, 2025 as soon as possible, working with both of its auditors where each auditor is responsible for their own periods ending in 2024 and 2025.